No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Anticoagulants / adverse effects*
-
Antidotes / therapeutic use
-
Antifibrinolytic Agents / therapeutic use*
-
Antithrombins / adverse effects
-
Blood Coagulation Factors / therapeutic use*
-
Charcoal / therapeutic use
-
Dabigatran / adverse effects
-
Factor Xa Inhibitors / adverse effects
-
Half-Life
-
Hemorrhage / chemically induced
-
Hemorrhage / therapy*
-
Humans
-
Pyrazoles / adverse effects
-
Pyridones / adverse effects
-
Renal Dialysis*
-
Rivaroxaban / adverse effects
-
Tranexamic Acid / therapeutic use*
-
Warfarin / adverse effects
Substances
-
Antibodies, Monoclonal, Humanized
-
Anticoagulants
-
Antidotes
-
Antifibrinolytic Agents
-
Antithrombins
-
Blood Coagulation Factors
-
Factor Xa Inhibitors
-
Pyrazoles
-
Pyridones
-
Charcoal
-
prothrombin complex concentrates
-
apixaban
-
Warfarin
-
Tranexamic Acid
-
idarucizumab
-
Rivaroxaban
-
Dabigatran